SCHEMBL29908697

SCHEMBL29908697

O=C1Nc2ccc3ncsc3c2C1=Cc1cnc[nH]1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLK2 Q86UE8 14/20 1.00
MAP3K11 Q16584 1/20 1.00
NEK7 Q8TDX7 1/20 1.00
NEK6 Q9HC98 1/20 1.00
MELK Q14680 2/20 0.69
CDK5 Q00535 3/20 0.51
MAPT P10636 2/20 0.51
CDK5R1 Q15078 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
PTK2B Q14289 1/20 0.51
CDK1 P06493 2/20 0.47
RET P07949 2/20 0.47
CDK2 P24941 2/20 0.47
MAPK1 P28482 2/20 0.47
KDR P35968 2/20 0.47
GSK3A P49840 2/20 0.47
GSK3B P49841 2/20 0.47
CDK7 P50613 2/20 0.47
CDK9 P50750 2/20 0.47
PDPK1 O15530 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2230665 1.00 TLK2 (1.00) TLK2MAP3K11NEK7NEK6MELK
SCHEMBL1395124 1.00 TLK2 (1.00) TLK2MAP3K11NEK7NEK6MELK
SCHEMBL1395126 1.00 TLK2 (1.00) TLK2MAP3K11NEK7NEK6MELK
SCHEMBL16231615 0.82 TLK2 (0.70) TLK2MAP3K11NEK7NEK6MELK
SCHEMBL23252181 0.81 MELK (1.00) TLK2MAP3K11NEK7NEK6MELK
SCHEMBL16234131 0.81 TLK2 (0.69) TLK2MAP3K11NEK7NEK6MELK
SCHEMBL16234132 0.81 MAP3K11 (0.68) TLK2MAP3K11NEK7NEK6MELK
SCHEMBL16234139 0.79 TLK2 (0.65) TLK2MAP3K11NEK7NEK6MELK
SCHEMBL16234143 0.78 TLK2 (0.64) TLK2MAP3K11NEK7NEK6MELK
SCHEMBL9886520 0.78 MAP3K11 (0.64) TLK2MAP3K11NEK7NEK6MELK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081309-A2 ENHANCING EXPRESSION OF LINE-1 ENCODED ORF2P FOR CANCER THERAPEUTICS The Johns Hopkins University (US) 2022-11-02 EP claimed
CN-119031921-A Annular RNA with 16bp-26bp double-stranded stem-loop structure for treating psoriasis or Alzheimer's disease 中国科学院分子细胞科学卓越创新中心 2024-11-26 CN disclosed
EP-4081309-A2 ENHANCING EXPRESSION OF LINE-1 ENCODED ORF2P FOR CANCER THERAPEUTICS The Johns Hopkins University (US) 2022-11-02 EP disclosed